help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Published ahead of print on March 4, 2005, doi:10.1164/rccm.200406-755OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200406-755OCv1
171/11/1260    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mochizuki, M.
Right arrow Articles by Sekizawa, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mochizuki, M.
Right arrow Articles by Sekizawa, K.
American Journal of Respiratory and Critical Care Medicine Vol 171. pp. 1260-1266, (2005)
© 2005 American Thoracic Society
doi: 10.1164/rccm.200406-755OC

Original Article

Role of 15-Deoxy{Delta}12,14 Prostaglandin J2 and Nrf2 Pathways in Protection against Acute Lung Injury

Mie Mochizuki, Yukio Ishii, Ken Itoh, Takashi Iizuka, Yuko Morishima, Toru Kimura, Takumi Kiwamoto, Yosuke Matsuno, Ahamed E. Hegab, Akihiro Nomura, Tohru Sakamoto, Koji Uchida, Masayuki Yamamoto and Kiyohisa Sekizawa

Department of Respiratory Medicine, and Institute of Basic Medical Sciences and Center for Tsukuba Advanced Research Alliance, University of Tsukuba, Tsukuba; and Laboratory of Food and Biodynamics, Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Japan

Correspondence and requests for reprints should be addressed to Yukio Ishii, M.D., Ph.D., Department of Respiratory Medicine, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba, Ibaraki 305, Japan. E-mail: ishii-y{at}md.tsukuba.ac.jp

Rationale: Acute lung injury (ALI) is a disease process that is characterized by diffuse inflammation in the lung parenchyma. Recent studies demonstrated that cyclooxygenase-2 (COX-2) induced at the late phase of inflammation aids in the resolution of inflammation by generating 15-deoxy-{Delta}12,14-prostaglandin J2 (15d-PGJ2). Transcription factor Nrf2 is activated by electrophiles and exerts antiinflammatory effects by inducing the gene expression of antioxidant and detoxification enzymes. Objectives: Because 15d-PGJ2 is an endogenous electrophile, we hypothesized that it protects against ALI by activating Nrf2. Methods: To test this hypothesis, we generated a reversible ALI model by intratracheal injection of carrageenin, an inducer of acute inflammation, whose stimulation has been known to induce COX-2. Main Results: We found that ALI induced by carrageenin was markedly exacerbated in Nrf2-knockout mice, compared with wild-type mice. Analysis of bronchoalveolar lavage fluids also revealed that the magnitude and the duration of acute inflammation, indicated by albumin concentration and the number of neutrophils, were significantly enhanced in Nrf2-knockout mice. Treatment of wild-type mice with NS-398, a selective COX-2 inhibitor, significantly exacerbated ALI to the level of Nrf2-knockout mice. In the lungs of NS-398–treated wild-type mice, both the accumulation of 15d-PGJ2 and the induction of Nrf2 target antioxidant genes were significantly attenuated. Exogenous administration of 15d-PGJ2 reversed the exacerbating effects of NS-398 with the induction of antioxidant genes. Conclusions: These results demonstrated in vivo that 15d-PGJ2 plays a protective role against ALI by exploiting the Nrf2-mediated transcriptional pathway.

Key Words: alveolar macrophages • cyclooxygenase-2 • inflammation • transcription factor




This article has been cited by other articles:


Home page
 Cancer Res.Home page
S. E. Dickinson, T. F. Melton, E. R. Olson, J. Zhang, K. Saboda, and G. T. Bowden
Inhibition of Activator Protein-1 by Sulforaphane Involves Interaction with Cysteine in the cFos DNA-Binding Domain: Implications for Chemoprevention of UVB-Induced Skin Cancer
Cancer Res., September 1, 2009; 69(17): 7103 - 7110.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
D. El Kebir, L. Jozsef, W. Pan, L. Wang, N. A. Petasis, C. N. Serhan, and J. G. Filep
15-Epi-lipoxin A4 Inhibits Myeloperoxidase Signaling and Enhances Resolution of Acute Lung Injury
Am. J. Respir. Crit. Care Med., August 15, 2009; 180(4): 311 - 319.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
J. Antoun, S. Goulitquer, Y. Amet, Y. Dreano, J.-P. Salaun, L. Corcos, and E. Plee-Gautier
CYP4F3B is induced by PGA1 in human liver cells: a regulation of the 20-HETE synthesis
J. Lipid Res., October 1, 2008; 49(10): 2135 - 2141.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
D. El Kebir, L. Jozsef, W. Pan, and J. G. Filep
Myeloperoxidase Delays Neutrophil Apoptosis Through CD11b/CD18 Integrins and Prolongs Inflammation
Circ. Res., August 15, 2008; 103(4): 352 - 359.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
O. Haworth and B. D. Levy
Endogenous lipid mediators in the resolution of airway inflammation
Eur. Respir. J., November 1, 2007; 30(5): 980 - 992.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Joo, M. Kwon, R. T. Sadikot, P. J. Kingsley, L. J. Marnett, T. S. Blackwell, R. S. Peebles Jr, Y. Urade, and J. W. Christman
Induction and Function of Lipocalin Prostaglandin D Synthase in Host Immunity
J. Immunol., August 15, 2007; 179(4): 2565 - 2575.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
Y. Tanaka, J. M. Maher, C. Chen, and C. D. Klaassen
Hepatic Ischemia-Reperfusion Induces Renal Heme Oxygenase-1 via NF-E2-Related Factor 2 in Rats and Mice
Mol. Pharmacol., March 1, 2007; 71(3): 817 - 825.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
S. Qin, A. P. McLaughlin, and G. W. De Vries
Protection of RPE Cells from Oxidative Injury by 15-Deoxy-{Delta}12,14-Prostaglandin J2 by Augmenting GSH and Activating MAPK
Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 5098 - 5105.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
G. Y. Park and J. W. Christman
Involvement of cyclooxygenase-2 and prostaglandins in the molecular pathogenesis of inflammatory lung diseases
Am J Physiol Lung Cell Mol Physiol, May 1, 2006; 290(5): L797 - L805.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
E. B. Milbrandt, A. Ishizaka, and D. C. Angus
Update in critical care 2005.
Am. J. Respir. Crit. Care Med., April 15, 2006; 173(8): 833 - 841.
[Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Ishii, K. Itoh, Y. Morishima, T. Kimura, T. Kiwamoto, T. IIzuka, A. E. Hegab, T. Hosoya, A. Nomura, T. Sakamoto, et al.
Transcription Factor Nrf2 Plays a Pivotal Role in Protection against Elastase-Induced Pulmonary Inflammation and Emphysema
J. Immunol., November 15, 2005; 175(10): 6968 - 6975.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Z. R. Healy, N. H. Lee, X. Gao, M. B. Goldring, P. Talalay, T. W. Kensler, and K. Konstantopoulos
Divergent responses of chondrocytes and endothelial cells to shear stress: Cross-talk among COX-2, the phase 2 response, and apoptosis
PNAS, September 27, 2005; 102(39): 14010 - 14015.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. Uhlig
Who Tidies Up the Lung?: Listen to Cox-2 and Nrf2
Am. J. Respir. Crit. Care Med., June 1, 2005; 171(11): 1198 - 1199.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2005 American Thoracic Society 		  Tobacco